| |
| |
|
| Insider
Information: |
Van Den Broek Richard |
| Relationship: |
Director |
| City: |
Newark |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
35,630 |
|
|
Indirect Shares
|
591,145 |
|
|
| Direct
Value |
$37,412 |
|
|
|
Indirect Value
|
$9,894,326 |
|
|
| Total
Shares |
626,775 |
|
|
| Total
Value |
$9,931,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
 -1.3%
|
 135.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Strategic Diagnostics Inc |
SDIX |
Director |
2012-05-15 |
35,630 |
2012-05-15 |
200,000 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Director |
|
0 |
2012-12-31 |
108,445 |
Premium* |
|
|
Response Genetics Inc |
RGDX |
Director |
|
0 |
2012-02-02 |
282,700 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
Director |
– • – |
2012-12-31 |
4 |
S |
$58.50 |
$419,476 |
I/I |
(7,171) |
108,445 |
0 |
-42.5% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • – |
2012-12-28 |
4 |
S |
$57.98 |
$1,064,125 |
I/I |
(18,354) |
108,445 |
0 |
-42.0% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • – |
2012-12-27 |
4 |
S |
$58.02 |
$692,239 |
I/I |
(11,931) |
126,799 |
0 |
-44.8% |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2012-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
35,630 |
0 |
- |
|
| RGDX |
Response Genetics Inc |
Director |
– • – |
2012-02-02 |
4 |
B |
$1.50 |
$150,000 |
I/I |
100,000 |
282,700 |
2.1 |
-21.6% |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2011-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
33,130 |
0 |
- |
|
| RGDX |
Response Genetics Inc |
Director |
– • – |
2010-12-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
182,700 |
|
-4.3% |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2010-08-23 |
4 |
B |
$1.88 |
$18,612 |
D/D |
9,900 |
30,630 |
2.39 |
-14.6% |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2010-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
20,730 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • – |
2009-12-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
138,730 |
|
146.9% |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
18,230 |
0 |
- |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2008-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,730 |
15,730 |
0 |
- |
|
| SDIX |
Strategic Diagnostics Inc |
Director |
– • – |
2008-03-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
200,000 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
